Director sold ~$58K of Doximity
Scheduled in advanceLoading…
Doximity
DOCS · NYSE · Health Care Technology
DOCS · NYSE · Health Care Technology
Health Care Technology company based in San Francisco, California.
In the last 90 days, no insider of Doximity reported an open-market purchase and 8 open-market sales worth about $624K. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$28.58
Last 12 months
Not enough history
Market value
Not available
Revenue
$157M
+7.3% vs the same quarter a year earlier
Free cash flow, last 12 months
$41.9M
This quarter $41.9M, a year earlier $62.1M
Net debt
—
Debt —, cash $274M, at Jun 30, 2026
Net income, last 12 months
$167M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 6, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
8 sales
$624K sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2026
$645M
+13.1% vs the year before
Net income, fiscal 2026
$196M
As reported in the annual filing
Shares outstanding
Not available
Reported per share class only, with no single total
In fiscal 2026 the company spent $432M buying back its own shares. Cash actually paid, from its cash-flow statement.
Director sold ~$58K of Doximity
Scheduled in advanceDirector sold ~$34K of Doximity
Scheduled in advanceOfficer sold ~$54K of Doximity
Scheduled in advanceDirector sold ~$50K of Doximity
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $72.75 on Oct 6, 2025 to $28.58 on Oct 5, 2026 (-60.7%). Disclosed activity in the last 12 months: 0 insider purchases, 21 insider sales (21 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.
Top officer leaving
“On April 13, 2026, the Company accepted her resignation as Chief Financial Officer.”
2 insiders sold ~$162K in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.